Schedule 13G ownership disclosure

ENVERIC BIOSCIENCES INC

Common Stock, $0.01 par value per share · CUSIP: 29405E505

Event date: 2025-12-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Braeden Lichti

    Shares: 29,920.00 · Class: 5.01%

  • Northstrive Fund II LP

    Shares: 25,915.00 · Class: 4.34%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-118884
Form type
SCHEDULE 13G
Filer
Braeden Lichti
CIK
CIK 1982476
Filed
Dec 05, 2025
Reporting period
Dec 03, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub